Authors

• Omar Alhalabi (ORCID: https://orcid.org/0000-0002-9658-2206)
• Aung Naing (ORCID: https://orcid.org/0000-0002-4803-8513)
• Daniel D. Karp (ORCID: https://orcid.org/0000-0002-5017-328X)
• Filip Janku
• David S. Hong (ORCID: https://orcid.org/0000-0001-8721-1609)
• Sarina A. Piha‐Paul (ORCID: https://orcid.org/0000-0001-9455-1660)
• Jordi Rodón (ORCID: https://orcid.org/0000-0001-6467-3632)
• Serdar A. Gurses (ORCID: https://orcid.org/0000-0002-8781-4554)
• Bülent Yılmaz (ORCID: https://orcid.org/0000-0002-9458-2253)
• Vivek Subbiah (ORCID: https://orcid.org/0000-0002-6064-6837)
• Siqing Fu (ORCID: https://orcid.org/0000-0002-1933-0419)
• Hassan Ahmed Momin
• Justin T. Moyers (ORCID: https://orcid.org/0000-0001-5139-1652)
• Nizar M. Tannir (ORCID: https://orcid.org/0000-0001-5559-8060)
• Mohamed A. Gouda (ORCID: https://orcid.org/0000-0003-4829-6739)
• Funda Meric‐Bernstam (ORCID: https://orcid.org/0000-0001-6816-6072)
• Bettzy Stephen (ORCID: https://orcid.org/0000-0003-1653-2012)
• Jeffrey How (ORCID: https://orcid.org/0000-0003-1446-9574)
• Chinenye Lynette Ejezie (ORCID: https://orcid.org/0000-0001-7335-8597)
• Denái R. Milton
• Ecaterina E Ileana Dumbrava (ORCID: https://orcid.org/0000-0002-1959-0536)

Institutions

• The University of Texas MD Anderson Cancer Center (US)
• Angeles Clinic and Research Institute (US)

Publication Details

Journal

Cancer Medicine

Published

2025-02-01

DOI

https://doi.org/10.1002/cam4.70280

Citations

2

Primary Topic

Renal and related cancers

Type

article

Field-Weighted Citation Impact

1.61

Funders

• Amgen
• Bristol-Myers Squibb
• Eli Lilly and Company
• Pfizer
• AstraZeneca
• GlaxoSmithKline
• Sanofi
• Gilead Sciences
• Spectrum Pharmaceuticals
• AbbVie
• F. Hoffmann-La Roche
• Karyopharm Therapeutics
• BioMarin Pharmaceutical
• Regeneron Pharmaceuticals
• Taiho Pharmaceutical
• Exelixis
• Cholangiocarcinoma Foundation
• Novocure
• National Comprehensive Cancer Network
• Five Prime Therapeutics
• Millendo Therapeutics
• Mersana Therapeutics
• BeiGene
• Incyte
• Calithera Biosciences
• Innovent Biologics
• Aileron Therapeutics
• Aminex Therapeutics
• F-star Therapeutics
• Puma Biotechnology
• Silverback Therapeutics
• MacroGenics
• Bayer HealthCare
• Eisai
• European Society for Medical Oncology
• PharmaMar
• Menarini Group
• Symphogen
• National Institutes of Health
• Genentech
• Samsung
• EMD Serono
• Chugai Pharmaceutical
• Takeda Oncology
• Loxo Oncology
• ImmunoMedics
• Principia Biopharma
• National Cancer Institute
• Daiichi Sankyo Europe